Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Radiomics-based assessment of Primary Sjogren's Syndrome from salivary gland ultrasonography images.

Vukicevic AM, Milic V, Zabotti A, Hocevar A, Di Lucia O, Filippou G, De Vita S, Frangi AF, Tzioufas A, Filipovic N.

IEEE J Biomed Health Inform. 2019 Jul 18. doi: 10.1109/JBHI.2019.2923773. [Epub ahead of print]

PMID:
31329136
2.

Enhancing medical data quality through data curation: a case study in primary Sjögren's syndrome.

Pezoulas VC, Kourou KD, Kalatzis F, Exarchos TP, Venetsanopoulou AI, Zampeli E, Gandolfo S, Skopouli FN, De Vita S, Tzioufas AG, Fotiadis DI.

Clin Exp Rheumatol. 2019 Jul 5. [Epub ahead of print]

PMID:
31287405
3.

The Second Greek-Israeli Symposium on Autoimmunity and Rheumatology: Success Through Synergy.

Sakkas LI, Bogdanos DP, Boumpas D, Mamouris Z, Gkoutzourelas A, Mavropoulos A, Tsouris Z, Liossis SN, Daoussis D, Vasilopoulos D, Tektonidou M, Tzioufas A, Efthymiou G, Dardiotis E, Kitas G, Sharif Κ, Blank M, Karussis D, Rimar D, Slobodin G, Porat-Katz BS, Vadasz Z, Amital H, Toubi E, Shoenfeld Y.

Isr Med Assoc J. 2019 Apr;21(4):292-297. No abstract available.

4.

Ablation of the Chaperone Protein ERdj5 Results in a Sjögren's Syndrome-Like Phenotype in Mice, Consistent With an Upregulated Unfolded Protein Response in Human Patients.

Apostolou E, Moustardas P, Iwawaki T, Tzioufas AG, Spyrou G.

Front Immunol. 2019 Mar 22;10:506. doi: 10.3389/fimmu.2019.00506. eCollection 2019.

5.

Medical data quality assessment: On the development of an automated framework for medical data curation.

Pezoulas VC, Kourou KD, Kalatzis F, Exarchos TP, Venetsanopoulou A, Zampeli E, Gandolfo S, Skopouli F, De Vita S, Tzioufas AG, Fotiadis DI.

Comput Biol Med. 2019 Apr;107:270-283. doi: 10.1016/j.compbiomed.2019.03.001. Epub 2019 Mar 7.

PMID:
30878889
6.

TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients.

Nezos A, Gkioka E, Koutsilieris M, Voulgarelis M, Tzioufas AG, Mavragani CP.

J Immunol Res. 2018 Dec 19;2018:6923213. doi: 10.1155/2018/6923213. eCollection 2018.

7.

Lymphomagenesis in Sjögren's syndrome: Predictive biomarkers towards precision medicine.

Goules AV, Tzioufas AG.

Autoimmun Rev. 2019 Feb;18(2):137-143. doi: 10.1016/j.autrev.2018.08.007. Epub 2018 Dec 17. Review.

PMID:
30572133
8.

Towards the Establishment of a Biomedical Ontology for the Primary Sjögren's Syndrome.

Pezoulas VC, Exarchos TP, Andronikou V, Varvarigou T, Tzioufas AG, De Vita S, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:4089-4092. doi: 10.1109/EMBC.2018.8513349.

PMID:
30441255
9.

Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.

Karagianni P, Nezos A, Ioakeim F, Tzioufas AG, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):86-89. Epub 2018 Nov 9.

PMID:
30418111
10.

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2019 Jan;18(1):93-106. doi: 10.1016/j.autrev.2018.08.003. Epub 2018 Nov 5. Review.

PMID:
30408582
11.

How can autoantibodies predict the long-term outcome of patients with interstitial lung disease? Results from a retrospective cohort study.

Kampolis CF, Venetsanopoulou AI, Karakontaki F, Polychronopoulos V, Vlachoyiannopoulos P, Tzioufas AG.

Autoimmun Rev. 2018 Nov;17(11):1124-1133. doi: 10.1016/j.autrev.2018.06.004. Epub 2018 Sep 11.

PMID:
30213691
12.

Decrease in the ratio of polyreactive IgG titers with IgG concentration is associated with long-term complications of primary Sjögren's syndrome.

Argyropoulou OD, Gunti S, Kapsogeorgou EK, Notkins AL, Tzioufas AG.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):239-240. Epub 2018 Aug 14. No abstract available.

13.

Severe cutaneous hand infection: Mycobacterium marinum in an immunosuppressed patient.

Argyropoulou OD, Zampeli E, Sipsas NV, Tzioufas AG, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1117. Epub 2018 Jul 19. No abstract available.

14.

Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.

Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.

Clin Rheumatol. 2019 Jan;38(1):125-132. doi: 10.1007/s10067-018-4267-z. Epub 2018 Aug 25.

PMID:
30145635
15.

Cryoglobulinaemia.

Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, Zignego AL, Ferri C.

Nat Rev Dis Primers. 2018 Aug 2;4(1):11. doi: 10.1038/s41572-018-0009-4. Review.

16.

Response to: 'Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?' by Nocturne et al.

Kapsogeorgou EK, Papageorgiou A, Protogerou AD, Voulgarelis M, Tzioufas AG.

Ann Rheum Dis. 2018 Jul 20. pii: annrheumdis-2018-214009. doi: 10.1136/annrheumdis-2018-214009. [Epub ahead of print] No abstract available.

PMID:
30030261
17.

Cohort Harmonization and Integrative Analysis From a Biomedical Engineering Perspective.

Kourou KD, Pezoulas VC, Georga EI, Exarchos TP, Tsanakas P, Tsiknakis M, Varvarigou T, De Vita S, Tzioufas A, Fotiadis DI.

IEEE Rev Biomed Eng. 2019;12:303-318. doi: 10.1109/RBME.2018.2855055. Epub 2018 Jul 11. Review.

PMID:
30004887
18.

Limited efficacy of targeted treatments in Sjögren's syndrome: why?

Tzioufas AG, Goules AV.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):27-28. Epub 2018 Jun 21. No abstract available.

19.

Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.

Kapsogeorgou EK, Papageorgiou A, Protogerou AD, Voulgarelis M, Tzioufas AG.

Ann Rheum Dis. 2018 Aug;77(8):1200-1207. doi: 10.1136/annrheumdis-2017-212639. Epub 2018 May 19.

PMID:
29779010
20.

Autoimmune or infectious disease? That is the question.

Constantinou CA, Fragoulis GE, Gakiopoulou Η, Tzioufas AG, Sipsas NV.

Clin Exp Rheumatol. 2018 May-Jun;36(3):517-518. Epub 2018 Mar 27. No abstract available.

PMID:
29600934
21.

Non-invasive vascular biomarkers in patients with Behçet's disease: review of the data and future perspectives.

Protogerou AD, Nasothimiou EG, Sfikakis PP, Tzioufas AG.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):100-107. Epub 2017 Oct 6. Review.

22.

Multiple primary squamous cell carcinomas of the lower lip and tongue arising in discoid lupus erythematosus: a case report.

Arvanitidou IE, Nikitakis NG, Georgaki M, Papadogeorgakis N, Tzioufas A, Sklavounou A.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Feb;125(2):e22-e30. doi: 10.1016/j.oooo.2017.08.012. Epub 2017 Aug 30.

PMID:
28967499
23.

Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study.

Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG.

Clin Rheumatol. 2018 Mar;37(3):737-747. doi: 10.1007/s10067-017-3835-y. Epub 2017 Sep 15.

PMID:
28914375
24.

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome.

Fragkioudaki S, Nezos A, Souliotis VL, Chatziandreou I, Saetta AA, Drakoulis N, Tzioufas AG, Voulgarelis M, Sfikakis PP, Koutsilieris M, Crow MK, Moutsopoulos HM, Mavragani CP.

Sci Rep. 2017 Aug 4;7(1):7354. doi: 10.1038/s41598-017-07347-w.

25.

International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.

Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2017 Sep;16(9):911-924. doi: 10.1016/j.autrev.2017.07.012. Epub 2017 Jul 11. Review.

PMID:
28705780
26.

Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract.

Spanou E, Kalisperati P, Pateras IS, Papalampros A, Barbouti A, Tzioufas AG, Kotsinas A, Sougioultzis S.

Front Genet. 2017 May 29;8:65. doi: 10.3389/fgene.2017.00065. eCollection 2017. Review.

27.

Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece.

Tzanetakos C, Tzioufas A, Goules A, Kourlaba G, Theodoratou T, Christou P, Maniadakis N.

Rheumatol Int. 2017 Sep;37(9):1441-1452. doi: 10.1007/s00296-017-3736-z. Epub 2017 May 18.

PMID:
28523420
28.

Autoantibodies in Autoimmune Diseases: Clinical and Critical Evaluation.

Kapsogeorgou EK, Tzioufas AG.

Isr Med Assoc J. 2016 Sep;18(9):519-524. Review.

29.

Insight into pathogenesis of Sjögren's syndrome: Dissection on autoimmune infiltrates and epithelial cells.

Goules AV, Kapsogeorgou EK, Tzioufas AG.

Clin Immunol. 2017 Sep;182:30-40. doi: 10.1016/j.clim.2017.03.007. Epub 2017 Mar 19. Review.

PMID:
28330683
30.

International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement.

Zignego AL, Ramos-Casals M, Ferri C, Saadoun D, Arcaini L, Roccatello D, Antonelli A, Desbois AC, Comarmond C, Gragnani L, Casato M, Lamprecht P, Mangia A, Tzioufas AG, Younossi ZM, Cacoub P; ISG-EHCV.

Autoimmun Rev. 2017 May;16(5):523-541. doi: 10.1016/j.autrev.2017.03.004. Epub 2017 Mar 7. Review.

31.

Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome.

Quartuccio L, Mavragani CP, Nezos A, Gandolfo S, Tzioufas AG, De Vita S.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):719-720. Epub 2017 Mar 8. No abstract available.

PMID:
28281461
32.

Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.

Sfikakis PP, Bournia VK, Sidiropoulos P, Boumpas DT, Drosos AA, Kitas GD, Konstantonis G, Liossis SN, Manoussakis MN, Sakkas L, Tektonidou M, Tzioufas AG, Vlachoyiannopoulos PG, Kani C, Paterakis P, Litsa P, Vassilopoulos D.

Clin Exp Rheumatol. 2017 Jul-Aug;35(4):579-585. Epub 2017 Mar 3.

PMID:
28281458
33.

Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.

Ramos-Casals M, Zignego AL, Ferri C, Brito-Zerón P, Retamozo S, Casato M, Lamprecht P, Mangia A, Saadoun D, Tzioufas AG, Younossi ZM, Cacoub P; International Study Group of Extrahepatic Manifestations related to HCV (ISG-EHCV).

J Hepatol. 2017 Jun;66(6):1282-1299. doi: 10.1016/j.jhep.2017.02.010. Epub 2017 Feb 20. Review. No abstract available.

PMID:
28219772
34.

Cyclophosphamide followed by rituximab for aggressive multiple-relapsing antineutrophil cytoplasmic antibody-associated vasculitis.

Lionaki S, Fragoulis GE, Venetsanopoulou A, Vlachoyiannopoulos P, Boletis JN, Tzioufas AG.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):155-164. Epub 2017 Jan 25.

PMID:
28134075
35.

Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study.

Lampropoulos CE, Orfanos P, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):192-200. Epub 2017 Jan 16.

PMID:
28094760
36.

Cell-specific epigenome-wide DNA methylation profile in long-term cultured minor salivary gland epithelial cells from patients with Sjögren's syndrome.

Charras A, Konsta OD, Le Dantec C, Bagacean C, Kapsogeorgou EK, Tzioufas AG, Pers JO, Bordron A, Renaudineau Y.

Ann Rheum Dis. 2017 Mar;76(3):625-628. doi: 10.1136/annrheumdis-2016-210167. Epub 2017 Jan 16.

PMID:
28093418
37.

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome.

Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, Bombardieri S, Ng WF, Tzioufas AG, Vitali C, Shirlaw P, Haacke E, Costa S, Bootsma H, Devauchelle-Pensec V, Radstake TR, Mariette X, Richards A, Stack R, Bowman SJ, Barone F; Sjögren's histopathology workshop group (appendix) from ESSENTIAL (EULAR Sjögren's syndrome study group).

Ann Rheum Dis. 2017 Jul;76(7):1161-1168. doi: 10.1136/annrheumdis-2016-210448. Epub 2016 Dec 13.

38.

Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease.

Fouka P, Alexopoulos H, Chatzi I, Dedos SG, Samiotaki M, Panayotou G, Politis P, Tzioufas A, Dalakas MC.

Neurol Neuroimmunol Neuroinflamm. 2016 Dec 5;4(1):e306. eCollection 2017 Jan.

39.

Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores.

Vlachogiannis NI, Nezos A, Tzioufas AG, Koutsilieris M, Moutsopoulos HM, Mavragani CP.

Clin Immunol. 2016 Dec;173:157-160. doi: 10.1016/j.clim.2016.10.015. Epub 2016 Nov 1.

PMID:
27810512
40.

International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement.

Ferri C, Ramos-Casals M, Zignego AL, Arcaini L, Roccatello D, Antonelli A, Saadoun D, Desbois AC, Sebastiani M, Casato M, Lamprecht P, Mangia A, Tzioufas AG, Younossi ZM, Cacoub P; ISG-EHCV coauthors.

Autoimmun Rev. 2016 Dec;15(12):1145-1160. doi: 10.1016/j.autrev.2016.09.006. Epub 2016 Sep 16. Review.

41.

Expression of type III interferons (IFNλs) and their receptor in Sjögren's syndrome.

Apostolou E, Kapsogeorgou EK, Konsta OD, Giotakis I, Saridaki MI, Andreakos E, Tzioufas AG.

Clin Exp Immunol. 2016 Dec;186(3):304-312. doi: 10.1111/cei.12865. Epub 2016 Oct 4.

42.

Primary Sjögren's syndrome: clinical phenotypes, outcome and the development of biomarkers.

Goules AV, Tzioufas AG.

Immunol Res. 2017 Feb;65(1):331-344. doi: 10.1007/s12026-016-8844-4. Review.

PMID:
27444892
43.

Sjögren syndrome.

Brito-Zerón P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M.

Nat Rev Dis Primers. 2016 Jul 7;2:16047. doi: 10.1038/nrdp.2016.47. Review.

PMID:
27383445
44.

Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression.

Konsta OD, Charras A, Le Dantec C, Kapsogeorgeou E, Bordron A, Brooks WH, Tzioufas AG, Pers JO, Renaudineau Y.

Bull Group Int Rech Sci Stomatol Odontol. 2016 Jun 28;53(1):e01.

PMID:
27352422
45.

Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis.

Lionaki S, Mavragani CP, Karras A, Liapis G, Somarakis G, Boletis JN, Drosos A, Tzioufas AG, Guillevin L, Moutsopoulos HM.

J Autoimmun. 2016 Aug;72:57-64. doi: 10.1016/j.jaut.2016.05.004. Epub 2016 May 15.

PMID:
27194577
46.

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies.

Seror R, Meiners P, Baron G, Bootsma H, Bowman SJ, Vitali C, Gottenberg JE, Theander E, Tzioufas A, De Vita S, Ramos-Casals M, Dörner T, Quartuccio L, Ravaud P, Mariette X; EULAR Sjögren Task Force.

Ann Rheum Dis. 2016 Nov;75(11):1945-1950. doi: 10.1136/annrheumdis-2015-208504. Epub 2016 Jan 25.

PMID:
27150113
47.

Clinical and financial burden of active lupus in Greece: a nationwide study.

Bertsias G, Karampli E, Sidiropoulos P, Gergianaki I, Drosos A, Sakkas L, Garyfallos A, Tzioufas A, Vassilopoulos D, Tsalapaki C, Sfikakis P, Panopoulos S, Athanasakis K, Perna A, Psomali D, Kyriopoulos J, Boumpas D.

Lupus. 2016 Oct;25(12):1385-94. doi: 10.1177/0961203316642310. Epub 2016 Apr 6.

PMID:
27055520
48.

Primary Sjӧgren's syndrome: Clinical phenotypes, outcome and the development of biomarkers.

Goules AV, Tzioufas AG.

Autoimmun Rev. 2016 Jul;15(7):695-703. doi: 10.1016/j.autrev.2016.03.004. Epub 2016 Mar 9. Review.

PMID:
26970487
49.

Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations.

Kampylafka EI, Alexopoulos H, Fouka P, Moutsopoulos HM, Dalakas MC, Tzioufas AG.

Lupus. 2016 Oct;25(11):1260-5. doi: 10.1177/0961203316636473. Epub 2016 Feb 27.

PMID:
26923281
50.

Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis.

Vadasz Z, Goldeberg Y, Halasz K, Rosner I, Valesini G, Conti F, Perricone C, Sthoeger Z, Bezalel SR, Tzioufas AG, Levin NA, Shoenfeld Y, Toubi E.

Clin Immunol. 2016 Mar;164:114-8. doi: 10.1016/j.clim.2016.02.004. Epub 2016 Feb 13.

PMID:
26883681

Supplemental Content

Loading ...
Support Center